SARS–CoV-2 infection of the placenta - Hosier, Hillary; Farhadian, Shelli F.; Morotti, Raffaella A.; Deshmukh, Uma; Lu-Culligan, Alice; Campbell, Katherine H.; Yasumoto, Yuki; Vogels, Chantal B.F.; Casanovas-Massana, Arnau; Vijayakumar, Pavithra; Geng, Bertie; Odio, Camila D.; et al. (The Journal of clinical investigation, 2020)
Keywords: Abortion, Therapeutic; Abruptio Placentae - etiology; Abruptio Placentae - pathology; Abruptio Placentae - virology; Adult; Analysis; Betacoronavirus - genetics; Betacoronavirus - isolation & purification; Betacoronavirus - pathogenicity; Clinical Medicine; Coronavirus Infections - complications; Coronavirus Infections - pathology; Coronavirus Infections - virology; Coronaviruses; COVID-19; Female; Health aspects; Humans; Microscopy, Electron, Transmission; Neonatology; Pandemics; Phylogeny; Placenta - pathology; Placenta - virology; Pneumonia, Viral - complications; Pneumonia, Viral - pathology; Pneumonia, Viral - virology; Pre-Eclampsia - etiology; Pre-Eclampsia - pathology; Pre-Eclampsia - virology; Pregnancy; Pregnancy Complications, Infectious - etiology; Pregnancy Complications, Infectious - pathology; Pregnancy Complications, Infectious - virology; Pregnancy Trimester, Second; Pregnant women; RNA, Viral - genetics; RNA, Viral - isolation & purification; SARS-CoV-2; Severe acute respiratory syndrome; Tranexamic acid; Venture capital companies; Viral Load; Connecticut; COVID-19; Molecular pathology; Reproductive Biology